Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens

Molecular Immunology

Volumn 37, Issue 18, 2000, Pages 1123-1130

  Park, Sung Sup ^a   Ryu, Chun Jeih ^a   Kang, Young Jun ^a   Kashmiri, S V S ^b   Hong, Hyo Jeong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antibody engineering; Bispecific antibody; Hepatitis B virus; Single chain antibody

Indexed keywords

BISPECIFIC ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

CRICETINAE; CRICETULUS GRISEUS; HEPATITIS B VIRUS;

EID: 0012870750     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00027-X     Document Type: Article

References (29)

1. Vaccine-induced escape mutant of hepatitis B virus
2. In vivo tumor targeting of a recombinant single-chain antigen binding protein
3. Design and production of novel tetravalent bispecific antibodies
4. 2 antibody containing thioether-linked Fab′γ fragments
5. Human-human hybridoma secreting hepatitis B virus-neutralizing antibodies
6. Costimulation by CD28 sFv expressed on the tumor cell surface or as a soluble bispecific molecule targeted to the L6 carcinoma antigen
7. Large surface proteins of hepatitis B virus containing the pre-S sequence
8. Engineering bispecific antibodies
9. Diabodies': Small bivalent and bispecific antibody fragments
10. Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
11. A synthetic peptide involving the pre-S2 region of hepatitis B virus; protective efficacy in chimpanzees
12. Cloning, expression and characterization of a murine-human chimeric antibody with specificity for pre-S2 surface antigen of hepatitis B virus
13. Efficient expression and characterization of hepatitis B virus preS2 antigen in Escherichia coli
14. Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimmer produced in bacteria
15. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity
16. Construction, binding properties, metabolism and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49
17. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus envelope proteins are virus-neutralizing and protective
18. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen
19. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to FcgammaRI and to HER-2/neu (MDX-210)
20. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen
21. Detection of specific sequences among DNA fragments separated by gel electrophoresis
22. Hybrid hybridima producing a bispecific monoclonal antibody that can focus effector T-cell activity
23. Bifunctional antibody: ZCE/CHA 111Indium BLEDTA-IV clinical imaging in colorectal carcinoma
24. Bispecific monoclonal antibodies from hybrid hybridomas
25. Immunotherapeutic potential of bispecific antibodies
26. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen